Table of Content

Global HIV Self Testing Market

1. INTRODUCTION
? MARKET DEFINITION
? MARKET SEGMENTATION
? PRODUCT OVERVIEW

2. ASSUMPTIONS AND ACRONYMS

3. RESEARCH METHODOLOGY
? RESEARCH PROCESS
? SECONDARY RESEARCH
? PRIMARY RESEARCH
? MARKET SIZE ESTIMATION

4. EXECUTIVE SUMMARY - GLOBAL HIV SELF TESTING MARKET

5. REGULATORY LANDSCAPE

6. ANALYSIS OF MARKET DYNAMICS
6.1. GROWTH DRIVERS
6.2. KEY TRENDS

7. KEY MARKET OPPORTUNITIES

8. MAJOR ROADBLOCKS FOR THE MARKET GROWTH

9. AVERAGE PRICING ANALYSIS

10. INDUSTRY RISK ANALYSIS
? DEMAND RISK ANALYSIS
? SUPPLY RISK ANALYSIS

11. GLOBAL HIV SELF TESTING MARKET OUTLOOK
11.1. GLOBAL MARKET SIZE AND FORECAST, 2018-2025F
? MARKET ANALYSIS
? BY VALUE (USD MILLION)
? BY VOLUME (MILLION UNITS)
11.2. GLOBAL HIV SELF TESTING MARKET SEGMENTATION, 2018-2025F
BY SAMPLE
o BLOOD, 2018-2025F (USD MILLION)
o ORAL FLUID, 2018-2025F (USD MILLION)
o URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
o LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
o IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
o 2nd, 2018-2025F (USD MILLION)
o 3rd, 2018-2025F (USD MILLION)
o 4th, 2018-2025F (USD MILLION)
11.2.1. BY REGIONS
11.2.1.1. SOUTH EAST ASIA HIV SELF TESTING MARKET, 2018-2025F (USD MILLION, MILLION UNITS)
? MARKET OVERVIEW
? MARKET VALUE AND VOLUME, 2018-2025F (USD MILLION, MILLION UNITS)
? ASSESSMENT OF MACROECONOMIC FACTORS
11.2.1.1.1. BY MARKET SEGMENTATION
BY SAMPLE
o BLOOD, 2018-2025F (USD MILLION)
o ORAL FLUID, 2018-2025F (USD MILLION)
o URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
o LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
o IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
o 2nd, 2018-2025F (USD MILLION)
o 3rd, 2018-2025F (USD MILLION)
o 4th, 2018-2025F (USD MILLION)
BY COUNTRY
o VIETNAM, 2018-2025F (USD MILLION)
? MARKET ANALYSIS
? MARKET SIZE, 2018-2025F (USD MILLION)
? BY SAMPLE
o BLOOD, 2018-2025F (USD MILLION)
o ORAL FLUID, 2018-2025F (USD MILLION)
o URINE, 2018-2025F (USD MILLION)
? BY PRODUCT TECHNOLOGY
o LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
o IMMUNOFILTRATION, 2018-2025F (USD MILLION)
? BY TEST GENERATION
o 2nd, 2018-2025F (USD MILLION)
o 3rd, 2018-2025F (USD MILLION)
o 4th, 2018-2025F (USD MILLION)
o MALAYSIA, 2018-2025F (USD MILLION)
? MARKET ANALYSIS
? MARKET SIZE, 2018-2025F (USD MILLION)
? BY SAMPLE
o BLOOD, 2018-2025F (USD MILLION)
o ORAL FLUID, 2018-2025F (USD MILLION)
o URINE, 2018-2025F (USD MILLION)
? BY PRODUCT TECHNOLOGY
o LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
• IMMUNOFILTRATION, 2018-2025F (USD MILLION)
• ? BY TEST GENERATION
• o 2nd, 2018-2025F (USD MILLION)
• o 3rd, 2018-2025F (USD MILLION)
• o 4th, 2018-2025F (USD MILLION)
• o INDONESIA, 2018-2025F (USD MILLION)
• ? MARKET ANALYSIS
• ? MARKET SIZE, 2018-2025F (USD MILLION)
• ? BY SAMPLE
• o BLOOD, 2018-2025F (USD MILLION)
• o ORAL FLUID, 2018-2025F (USD MILLION)
• o URINE, 2018-2025F (USD MILLION)
• ? BY PRODUCT TECHNOLOGY
• o LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
• o IMMUNOFILTRATION, 2018-2025F (USD MILLION)
• ? BY TEST GENERATION
• o 2nd, 2018-2025F (USD MILLION)
• o 3rd, 2018-2025F (USD MILLION)
• o 4th, 2018-2025F (USD MILLION)
• o THAILAND, 2018-2025F (USD MILLION)
• ? MARKET ANALYSIS
• ? MARKET SIZE, 2018-2025F (USD MILLION)
• ? BY SAMPLE
• o BLOOD, 2018-2025F (USD MILLION)
• o ORAL FLUID, 2018-2025F (USD MILLION)
• o URINE, 2018-2025F (USD MILLION)
• ? BY PRODUCT TECHNOLOGY
• o LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
• o IMMUNOFILTRATION, 2018-2025F (USD MILLION)
• ? BY TEST GENERATION
• o 2nd, 2018-2025F (USD MILLION)
• o 3rd, 2018-2025F (USD MILLION)
• o 4th, 2018-2025F (USD MILLION)
• o SINGAPORE, 2018-2025F (USD MILLION)
• ? MARKET ANALYSIS
• ? MARKET SIZE, 2018-2025F (USD MILLION)
• ? BY SAMPLE
• o BLOOD, 2018-2025F (USD MILLION)
• o ORAL FLUID, 2018-2025F (USD MILLION)
• o URINE, 2018-2025F (USD MILLION)
• ? BY PRODUCT TECHNOLOGY
• o LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
• o IMMUNOFILTRATION, 2018-2025F (USD MILLION)
• ? BY TEST GENERATION
• o 2nd, 2018-2025F (USD MILLION)
• o 3rd, 2018-2025F (USD MILLION)
• o 4th, 2018-2025F (USD MILLION)
• o PHILIPPINES, 2018-2025F (USD MILLION)
• ? MARKET ANALYSIS
• ? MARKET SIZE, 2018-2025F (USD MILLION)
• ? BY SAMPLE
• o BLOOD, 2018-2025F (USD MILLION)
• o ORAL FLUID, 2018-2025F (USD MILLION)
• o URINE, 2018-2025F (USD MILLION)
• ? BY PRODUCT TECHNOLOGY
• o LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
• o IMMUNOFILTRATION, 2018-2025F (USD MILLION)
• ? BY TEST GENERATION
• o 2nd, 2018-2025F (USD MILLION)
• o 3rd, 2018-2025F (USD MILLION)
• o 4th, 2018-2025F (USD MILLION)
11.2.1.2. LATIN AMERICA HIV SELF TESTING MARKET, 2018-2025F (USD MILLION, MILLION UNITS)
? MARKET ANALYSIS
? MARKET VALUE AND VOLUME, 2018-2025F (USD MILLION, MILLION UNITS)
? ASSESSMENT OF MACROECONOMIC FACTORS
11.2.1.2.1. BY MARKET SEGMENTATION
BY SAMPLE
o BLOOD, 2018-2025F (USD MILLION)
o ORAL FLUID, 2018-2025F (USD MILLION)
o URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
o LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
o IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
o 2nd, 2018-2025F (USD MILLION)
o 3rd, 2018-2025F (USD MILLION)
o 4th, 2018-2025F (USD MILLION)
BY COUNTRY
o BRAZIL, 2018-2025F (USD MILLION)
? MARKET ANALYSIS
? MARKET SIZE, 2018-2025F (USD MILLION)
? BY SAMPLE
o BLOOD, 2018-2025F (USD MILLION)
o ORAL FLUID, 2018-2025F (USD MILLION)
o URINE, 2018-2025F (USD MILLION)
? BY PRODUCT TECHNOLOGY
o LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
o IMMUNOFILTRATION, 2018-2025F (USD MILLION)
? BY TEST GENERATION
o 2nd, 2018-2025F (USD MILLION)
o 3rd, 2018-2025F (USD MILLION)
o 4th, 2018-2025F (USD MILLION)
o MEXICO, 2018-2025F (USD MILLION)
? MARKET ANALYSIS
? MARKET SIZE, 2018-2025F (USD MILLION)
? BY SAMPLE
o BLOOD, 2018-2025F (USD MILLION)
o ORAL FLUID, 2018-2025F (USD MILLION)
o URINE, 2018-2025F (USD MILLION)
? BY PRODUCT TECHNOLOGY
o LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
o IMMUNOFILTRATION, 2018-2025F (USD MILLION)
? BY TEST GENERATION
o 2nd, 2018-2025F (USD MILLION)
o 3rd, 2018-2025F (USD MILLION)
o 4th, 2018-2025F (USD MILLION)
o ARGENTINA, 2018-2025F (USD MILLION)
? MARKET ANALYSIS
? MARKET SIZE, 2018-2025F (USD MILLION)
? BY SAMPLE
o BLOOD, 2018-2025F (USD MILLION)
o ORAL FLUID, 2018-2025F (USD MILLION)
o URINE, 2018-2025F (USD MILLION)
? BY PRODUCT TECHNOLOGY
o LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
o IMMUNOFILTRATION, 2018-2025F (USD MILLION)
? BY TEST GENERATION
o 2nd, 2018-2025F (USD MILLION)
o 3rd, 2018-2025F (USD MILLION)
o 4th, 2018-2025F (USD MILLION)
o PERU, 2018-2025F (USD MILLION)
? MARKET ANALYSIS
? MARKET SIZE, 2018-2025F (USD MILLION)
? BY SAMPLE
o BLOOD, 2018-2025F (USD MILLION)
o ORAL FLUID, 2018-2025F (USD MILLION)
o URINE, 2018-2025F (USD MILLION)
? BY PRODUCT TECHNOLOGY
o LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
o IMMUNOFILTRATION, 2018-2025F (USD MILLION)
? BY TEST GENERATION
o 2nd, 2018-2025F (USD MILLION)
o 3rd, 2018-2025F (USD MILLION)
o 4th, 2018-2025F (USD MILLION)
o VENEZUELA, 2018-2025F (USD MILLION)
? MARKET ANALYSIS
? MARKET SIZE, 2018-2025F (USD MILLION)
? BY SAMPLE
o BLOOD, 2018-2025F (USD MILLION)
o ORAL FLUID, 2018-2025F (USD MILLION)
o URINE, 2018-2025F (USD MILLION)
? BY PRODUCT TECHNOLOGY
o LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
o IMMUNOFILTRATION, 2018-2025F (USD MILLION)
? BY TEST GENERATION
o 2nd, 2018-2025F (USD MILLION)
o 3rd, 2018-2025F (USD MILLION)
o 4th, 2018-2025F (USD MILLION)
o CHILE, 2018-2025F (USD MILLION)
? MARKET ANALYSIS
? MARKET SIZE, 2018-2025F (USD MILLION)
? BY SAMPLE
o BLOOD, 2018-2025F (USD MILLION)
o ORAL FLUID, 2018-2025F (USD MILLION)
o URINE, 2018-2025F (USD MILLION)
? BY PRODUCT TECHNOLOGY
o LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
o IMMUNOFILTRATION, 2018-2025F (USD MILLION)
? BY TEST GENERATION
o 2nd, 2018-2025F (USD MILLION)
o 3rd, 2018-2025F (USD MILLION)
o 4th, 2018-2025F (USD MILLION)
o CUBA, 2018-2025F (USD MILLION)
? MARKET ANALYSIS
? MARKET SIZE, 2018-2025F (USD MILLION)
? BY SAMPLE
o BLOOD, 2018-2025F (USD MILLION)
o ORAL FLUID, 2018-2025F (USD MILLION)
o URINE, 2018-2025F (USD MILLION)
? BY PRODUCT TECHNOLOGY
o LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
o IMMUNOFILTRATION, 2018-2025F (USD MILLION)
? BY TEST GENERATION
o 2nd, 2018-2025F (USD MILLION)
o 3rd, 2018-2025F (USD MILLION)
o 4th, 2018-2025F (USD MILLION)

12. COMPANY PROFILES
• CHEMBIO
? DETAILED OVERVIEW
? ASSESSMENT OF KEY PRODUCT OFFERINGS
? ANALYSIS OF GROWTH STRATEGIES
? KEY COLLABORATIONS AND JOINT VENTURES
? KEY MERGERS AND ACQUISITIONS
? RECENT NEWS AND DEVELOPMENTS
? KEY CLIENTS AND PARTNERS
? EXHAUSTIVE ANALYSIS ON KEY FINANCIAL INDICATORS
• ORA SURE TECHNOLOGIES
• WAMA DIAGN?STICA
• ECO DIAGN?STICA
• ORANGE LIFE
• EBRAM PRODUTOS LABORATORIAIS LTDA.

13. STRATEGIC RECOMMENDATIONS